Safety and Effectiveness of Glucagon-like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease. Anderson SR, Ayoub M, Coats S, McHenry S, et al. Am J Gastroenterol 2024 Nov 14. doi: 10.14309/ajg.0000000000003208.

Read + Share

Amedeo Smart

Independent Medical Education

Anderson SR, Ayoub M, Coats S, McHenry S, et al. Safety and Effectiveness of Glucagon-like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease. Am J Gastroenterol 2024 Nov 14. doi: 10.14309/ajg.0000000000003208.
PMID: 39717004